HDEF stock forecast, quote, news & analysis

Key Takeaways

• HDEF is a passively managed exchange-traded fund (ETF) that tracks the MSCI EAFE High Dividend Yield Index, targeting high-dividend, quality companies across developed markets outside the United States and Canada.
• The fund holds roughly 130 large-cap stocks, with the heaviest sector exposure in financials (about 27%), consumer staples (~18%), health care (~14%), and energy (~14%).
• With a net expense ratio of 0.09% and approximately $2.4 billion in assets under management (AUM), HDEF is a low-cost vehicle for international dividend income, carrying a yield in the mid-to-high 3% range.
• Over the trailing 30 days the fund advanced roughly 5.6%, a stronger move than its essentially flat quarterly trend.
• Top positions Shell plc, Roche, Novartis, and Nestlé exert outsized influence on both the fund's income stream and its price performance.
• Because nearly all holdings are denominated in foreign currencies, movements in the euro, British pound, Swiss franc, and Japanese yen materially affect returns for U.S.-based investors.
• For additional detail, explore Price Targets and Forecast on dedicated pages covering this ticker.
• Discover automated strategies and signals by browsing Trending AI Robots.

Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF) Overview

HDEF is a passively managed, index-based ETF that seeks to replicate the performance of the MSCI EAFE High Dividend Yield Index. The underlying index is designed to reflect equities in developed markets outside North America that exhibit higher dividend income and quality characteristics than the broader MSCI EAFE Index, with an emphasis on sustainability and persistence of those traits. The fund invests the vast majority of its assets in the index's component securities.

The portfolio spans more than 120 holdings, concentrated in large-cap names. The largest positions include Shell plc, Roche Holding, Novartis, Nestlé, Allianz, TotalEnergies, Iberdrola, and Unilever. From a sector standpoint, financials lead at roughly 27% of assets, followed by consumer staples (~18%), health care (~14%), and energy (~14%). Geographically, the fund is dominated by Europe, with Switzerland, the United Kingdom, France, and Germany among the largest country weightings, alongside notable exposure to Japan and Singapore. The fund's net expense ratio is 0.09%.

Industry and Thematic Landscape

HDEF operates squarely within the international dividend-income theme, a category shaped by value-oriented sectors that tend to pay consistent distributions. The fund's heavy tilt toward financials, staples, health care, and energy means its behavior is closely tied to European banks and insurers, global pharmaceutical pricing, energy commodity cycles, and defensive consumer demand.

The broader macroeconomic environment has reinforced several of these exposures. Elevated interest rates have supported net interest margins for European and Japanese banks and insurers, while energy holdings have benefited from firm oil and gas prices. At the same time, defensive sectors such as staples and health care have provided relative stability during periods of market uncertainty. Currency dynamics remain a persistent structural factor: a stronger U.S. dollar can dampen the value of foreign dividends and capital gains, while a weaker dollar tends to amplify returns.

Performance and Positioning Snapshot

Over the trailing 30 days, HDEF gained approximately 5.6%, recovering from a drawdown in late September and early October. The move reflected broad strength across the fund's financial and energy positions, which account for a large share of its assets. Over the trailing quarter, however, the fund has been essentially flat, having traded in a range with a dip toward the low-$32 level before rebounding toward the mid-$34 range.

Several of the fund's largest holdings have been important contributors. European insurers and banks, buoyed by resilient earnings and a favorable rate backdrop, have supported the financials sleeve. Energy names such as Shell and TotalEnergies have tracked commodity strength, while large pharmaceutical and consumer staples positions have provided ballast. The contrast between the recent 30-day advance and the flatter quarterly picture underscores a market that has been range-bound overall, punctuated by short bursts of sector rotation.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. It is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For investors evaluating international dividend strategies such as HDEF, the screener can help isolate comparable funds and stocks by sector, yield, momentum, and risk characteristics. Explore the AI Screener to refine your research process.

2026 Outlook and Key Factors to Monitor

Looking ahead, several structural factors are likely to shape HDEF's performance through 2026. Monetary policy across Europe, the United Kingdom, and Japan will remain central: the pace and direction of interest-rate moves will directly influence the earnings of the fund's substantial financials sleeve and the relative appeal of dividend income versus fixed income.

Inflation trends and energy prices will also matter, given the fund's meaningful energy weighting and the sensitivity of consumer staples margins to input costs. The earnings cycles of major pharmaceutical holdings, including patent expiration dynamics and pipeline developments, represent a company-specific risk worth monitoring. Currency movements between the U.S. dollar and major developed-market currencies will continue to add or subtract from total returns. Finally, capital flows into international dividend strategies and the competitive landscape among low-cost international income ETFs may influence both the fund's asset base and its long-term appeal. None of these factors constitute a price prediction; rather, they are the primary themes likely to drive the fund's risk-and-return profile in the months ahead.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations